@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@xconomy.com 5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
@venturebeat.com 7 years ago
Seven Bridges Announces Scientific Advisory Board
@theverge.com 9 years ago
England will sequence the genomes of 100,000 humans to tackle cancer and rare diseases